Rutin nanosuspension for potential management of osteoporosis: effect of particle size reduction on oral bioavailability, in vitro and in vivo activity

References

• Abdel Naim AB, Alghamdi AA, Algandaby MM, Al Abbasi FA, Al Abd AM, Eid BG, Abdallah HM, El Halawany AM. 2018. Rutin isolated from chrozophora tinctoria enhances bone cell proliferation and ossification markers. Oxid Med Cell Longev. 2018:1–10. doi.org/10.1155/2018/5106469.
   Web of Science ®Google Scholar
• Aditya N, Yang H, Kim S, Ko S. 2015. Fabrication of amorphous curcumin nanosuspensions using β-lactoglobulin to enhance solubility, stability, and bioavailability. Colloids Surf B Biointerfaces. 127:114–121.
   PubMed Web of Science ®Google Scholar
• Afifi SA, Hassan MA, Abdelhameed AS, Elkhodairy KA. 2015. Nanosuspension: an emerging trend for bioavailability enhancement of etodolac. Int J Polym Sci. 2015:1–16. doi.org/10.1155/2015/938594.
   Web of Science ®Google Scholar
• Anderson J, Ambrose W, Garner S. 1998. Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Exp Biol Med. 217(3):345–350.
   Web of Science ®Google Scholar
• Ansari MJ, Anwer MK, Jamil S, Al-Shdefat R, Ali BE, Ahmad MM, Ansari MN. 2016. Enhanced oral bioavailability of insulin-loaded solid lipid nanoparticles: pharmacokinetic bioavailability of insulin-loaded solid lipid nanoparticles in diabetic rats. Drug Deliv. 23(6):1972–1979.
   PubMed Web of Science ®Google Scholar
• Attari Z, Bhandari A, Jagadish P, Lewis S. 2016. Enhanced ex vivo intestinal absorption of olmesartan medoxomil nanosuspension: preparation by combinative technology. Saudi Pharm J. 24(1):57–63.
   PubMed Web of Science ®Google Scholar
• Bancroft J, Cook H. 1984. Manual of histological techniques. New York: Churchill Livingstone.
   Google Scholar
• Banfi G, Iorio EL, Corsi MM. 2008. Oxidative stress, free radicals and bone remodeling. Clin Chem Lab Med. 46(11):1550–1555.
   PubMed Web of Science ®Google Scholar
• Bernabei R, Martone AM, Ortolani E, Landi F, Marzetti E. 2014. Screening, diagnosis and treatment of osteoporosis: a brief review. Clin Cases Miner Bone Metab. 11(3):201–207.
   PubMedGoogle Scholar
• Bull H, Murray PG, Thomas D, Fraser A, Nelson PN. 2002. Acid phosphatases. J Clin Pathol. 55(2):65–72.
   Web of Science ®Google Scholar
• Canpolat S, Tug N, Seyran A, Kumru S, Yilmaz B. 2010. Effects of raloxifene and estradiol on bone turnover parameters in intact and ovariectomized rats. J Physiol Biochem. 66(1):23–28.
   PubMed Web of Science ®Google Scholar
• Cao G. 2004. Nanostructures and nanomaterials: synthesis, properties and applications. 2nd ed. Singapore: World Scientific.
   Google Scholar
• Chakraborti CK, Sahoo S, Behera PK. 2015. Effect of different polymers on in vitro and ex vivo permeability of ofloxacin from its mucoadhesive suspensions. Saudi Pharm J. 23(2):195–201.
   PubMed Web of Science ®Google Scholar
• Chiavarini M, Naldini G, Fabiani R. 2020. The role of diet in osteoporotic fracture healing: a systematic review. Curr Osteoporos Rep. doi.org/10.1007/s11914-020-00573-8
   PubMed Web of Science ®Google Scholar
• Chisari E, Shivappa N, Vyas S. 2019. Polyphenol-rich foods and osteoporosis. Curr Pharm Des. 25(22):2459–2466.
   PubMed Web of Science ®Google Scholar
• Choi J-Y, Yoo JY, Kwak H-S, Nam BU, Lee J. 2005. Role of polymeric stabilizers for drug nanocrystal dispersions. Curr Appl Phys. 5(5):472–474.
   Web of Science ®Google Scholar
• Das MK, Kalita B. 2014. Design and evaluation of phyto-phospholipid complexes (phytosomes) of rutin for transdermal application. J Appl Pharm Sci. 4(10):051–057.
   Google Scholar
• dos Santos AM, Carvalho FC, Teixeira DA, Azevedo DL, de Barros WM, Gremião M. 2017. Computational and experimental approaches for development of methotrexate nanosuspensions by bottom-up nanoprecipitation. Int J Pharm. 524(1–2):330–338.
   PubMedGoogle Scholar
• Fincher JH. 1968. Particle size of drugs and its relationship to absorption and activity. J Pharm Sci. 57(11):1825–1835.
   PubMed Web of Science ®Google Scholar
• Fuggle NR, Curtis EM, Ward KA, Harvey NC, Dennison EM, Cooper C. 2019. Fracture prediction, imaging and screening in osteoporosis. Nat Rev Endocrinol. 15(9):535–547.
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Levancini M. 2014. Hormone replacement therapy and the prevention of postmenopausal osteoporosis. Prz Menopauzalny. 13(4):213–220.
   PubMedGoogle Scholar
• Gao Y, Li Z, Sun M, Guo C, Yu A, Xi Y, Cui J, Lou H, Zhai G. 2011. Preparation and characterization of intravenously injectable curcumin nanosuspension. Drug Deliv. 18(2):131–142.
   PubMed Web of Science ®Google Scholar
• Gera S, Talluri S, Rangaraj N, Sampathi S. 2017. Formulation and evaluation of naringenin nanosuspensions for bioavailability enhancement. AAPS PharmSciTech. 18(8):3151–3162.
   PubMed Web of Science ®Google Scholar
• Golub EE, Boesze-Battaglia K. 2007. The role of alkaline phosphatase in mineralization. Curr Opin Orthop. 18(5):444–448.
   Google Scholar
• Guo Y, Shen L, Lu Y, Li H, Min K, Li L, Yu C, Zheng X. 2016. Preparation of rutin-liposome drug delivery systems and evaluation on their in vitro. Antioxidant Activity CHM. 8(4):371–375.
   Google Scholar
• Habauzit V, Sacco SM, Gil-Izquierdo A, Trzeciakiewicz A, Morand C, Barron D, Pinaud S, Offord E, Horcajada M-N. 2011. Differential effects of two citrus flavanones on bone quality in senescent male rats in relation to their bioavailability and metabolism. Bone. 49(5):1108–1116.
   PubMed Web of Science ®Google Scholar
• Hao J, Gao Y, Zhao J, Zhang J, Li Q, Zhao Z, Liu J. 2015. Preparation and optimization of resveratrol nanosuspensions by antisolvent precipitation using Box–Behnken design. AAPS PharmSciTech. 16(1):118–128.
   PubMed Web of Science ®Google Scholar
• He S, Yang H, Zhang R, Li Y, Duan L. 2015. Preparation and in vitro-in vivo evaluation of teniposide nanosuspensions. Int J Pharm. 478(1):131–137.
   PubMedGoogle Scholar
• Horcajada Molteni MN, Crespy V, Coxam V, Davicco MJ, Rémésy C, Barlet JP. 2000. Rutin inhibits ovariectomy‐induced osteopenia in rats. J Bone Miner Res. 15(11):2251–2258.
   PubMed Web of Science ®Google Scholar
• Hyun H, Park H, Jeong J, Kim J, Kim H, Oh HI, Hwang HS, Kim HH. 2014. Effects of watercress containing rutin and rutin alone on the proliferation and osteogenic differentiation of human osteoblast-like MG-63 cells. Korean J Physiol Pharmacol. 18(4):347–352.
   PubMed Web of Science ®Google Scholar
• Ismail F, Epstein S, Pacifici R, Droke D, Thomas S, Avioli L. 1986. Serum bone GLA protein (BGP) and other markers of bone mineral metabolism in postmenopausal osteoporosis. Calcif Tissue Int. 39(4):230–233.
   PubMed Web of Science ®Google Scholar
• Ivaska KK, Hentunen TA, Vääräniemi J, Ylipahkala H, Pettersson K, Väänänen HK. 2004. Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro. J Biol Chem. 279(18):18361–18369.
   PubMed Web of Science ®Google Scholar
• Jain A, Pooladanda V, Bulbake U, Doppalapudi S, Rafeeqi TA, Godugu C, Khan W. 2017. Liposphere mediated topical delivery of thymoquinone in the treatment of psoriasis. Nanomedicine. 13(7):2251–2262.
   PubMed Web of Science ®Google Scholar
• Jiang T, Han N, Zhao B, Xie Y, Wang S. 2012. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation. Drug Dev Ind Pharm. 38(10):1230–1239.
   PubMed Web of Science ®Google Scholar
• Ju H-Y, Hu K-X, Zhao G-W, Tang Z-S, Song X. 2019. Design, preparation, and characterization of dioscin nanosuspensions and evaluation of their protective effect against carbon tetrachloride-induced acute liver injury in mice. Evid Based Complementary Altern Med. 2019:1–16. doi.org/10.1155/2019/3907915.
   Web of Science ®Google Scholar
• Kakran M, Sahoo NG, Tan I-L, Li L. 2012. Preparation of nanoparticles of poorly water-soluble antioxidant curcumin by antisolvent precipitation methods. J Nanopart Res. 14(3):1–11.
   PubMed Web of Science ®Google Scholar
• Kamel R, Basha M. 2013. Preparation and in vitro evaluation of rutin nanostructured liquisolid delivery system. Bull Fac Pharm Cairo Univ. 51(2):261–272.
   Google Scholar
• Keck CM, Müller RH. 2006. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm. 62(1):3–16.
   PubMed Web of Science ®Google Scholar
• Kesisoglou F, Panmai S, Wu Y. 2007. Nanosizing—oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev. 59(7):631–644.
   PubMed Web of Science ®Google Scholar
• Khalifa TI, Muhtadi FJ, Hassan MM. 1983. Rutin. Analytical profiles of drug substances. Cambridge: Academic Press, Inc.
   Google Scholar
• Kuntic V, Pejic N, Ivkovic B, Vujic Z, Ilic K, Micic S, Vukojevic V. 2007. Isocratic RP-HPLC method for rutin determination in solid oral dosage forms. J Pharm Biomed Anal. 43(2):718–721.
   PubMed Web of Science ®Google Scholar
• Kyung T-W, Lee J-E, Shin H-H, Choi H-S. 2008. Rutin inhibits osteoclast formation by decreasing reactive oxygen species and TNF-α by inhibiting activation of NF-κB. Exp Mol Med. 40(1):52–58.
   PubMed Web of Science ®Google Scholar
• Lasota A, Danowska-Klonowska D. 2004. Experimental osteoporosis-different methods of ovariectomy in female white rats. Rocz Akad Med Bialymst. 49(Suppl 1):129–131.
   PubMedGoogle Scholar
• Lee IW, Li J, Chen X, Park HJ. 2017. Fabrication of electrospun antioxidant nanofibers by rutin‐pluronic solid dispersions for enhanced solubility. J Appl Polym. 134(21):1–10.
   Web of Science ®Google Scholar
• Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, et al. 2007. Endocrine regulation of energy metabolism by the skeleton. Cell. 130(3):456–469.
   PubMed Web of Science ®Google Scholar
• Lewies A, Wentzel JF, Jordaan A, Bezuidenhout C, Du Plessis LH. 2017. Interactions of the antimicrobial peptide nisin Z with conventional antibiotics and the use of nanostructured lipid carriers to enhance antimicrobial activity. Int J Pharm. 526(1-2):244–253.
   PubMedGoogle Scholar
• Liu D, Xu H, Tian B, Yuan K, Pan H, Ma S, Yang X, Pan W. 2012. Fabrication of carvedilol nanosuspensions through the anti-solvent precipitation–ultrasonication method for the improvement of dissolution rate and oral bioavailability. AAPS PharmSciTech. 13(1):295–304.
   PubMed Web of Science ®Google Scholar
• Liversidge GG, Cundy KC. 1995. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int J Pharm. 125(1):91–97.
   Web of Science ®Google Scholar
• Lonare AA, Patel SR. 2013. Antisolvent crystallization of poorly water soluble drugs. IJCEA. 4(5):337–341.
   Google Scholar
• Macedo AS, Quelhas S, Silva AM, Souto EB. 2014. Nanoemulsions for delivery of flavonoids: formulation and in vitro release of rutin as model drug. Pharm Dev Technol. 19(6):677–680.
   PubMed Web of Science ®Google Scholar
• Matteucci ME, Hotze MA, Johnston KP, Williams RO. 2006. Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization. Langmuir. 22(21):8951–8959.
   PubMed Web of Science ®Google Scholar
• Matteucci ME, Paguio JC, Miller MA, Williams Iii RO, Johnston KP. 2008. Flocculated amorphous nanoparticles for highly supersaturated solutions. Pharm Res. 25(11):2477–2487.
   PubMed Web of Science ®Google Scholar
• Mauludin R, Müller RH, Keck CM. 2009a. Development of an oral rutin nanocrystal formulation. Int J Pharm. 370(1–2):202–209.
   PubMed Web of Science ®Google Scholar
• Mauludin R, Müller RH, Keck CM. 2009b. Kinetic solubility and dissolution velocity of rutin nanocrystals. Eur J Pharm Sci. 36(4–5):502–510.
   PubMed Web of Science ®Google Scholar
• Mishra PR, Al Shaal L, Müller RH, Keck CM. 2009. Production and characterization of hesperetin nanosuspensions for dermal delivery. Int J Pharm. 371(1–2):182–189.
   PubMed Web of Science ®Google Scholar
• Muhammad SI, Maznah I, Mahmud RB, Esmaile MF, Zuki A. 2013. Bone mass density estimation: Archimede’s principle versus automatic X-ray histogram and edge detection technique in ovariectomized rats treated with germinated brown rice bioactives. Clin Interv Aging. 8:1421–1431.
   PubMed Web of Science ®Google Scholar
• Neerati P, Bedada SK. 2015. Effect of diosmin on the intestinal absorption and pharmacokinetics of fexofenadine in rats. Pharmacol Rep. 67(2):339–344.
   PubMed Web of Science ®Google Scholar
• Obeidat WM, Sallam A-SA. 2014. Evaluation of tadalafil nanosuspensions and their PEG solid dispersion matrices for enhancing its dissolution properties. AAPS PharmSciTech. 15(2):364–374.
   PubMed Web of Science ®Google Scholar
• Paczkowska M, Mizera M, Piotrowska H, Szymanowska-Powałowska D, Lewandowska K, Goscianska J, Pietrzak R, Bednarski W, Majka Z, Cielecka-Piontek J. 2015. Complex of rutin with β-cyclodextrin as potential delivery system. PLOS One. 10(3):e0120858.
   PubMed Web of Science ®Google Scholar
• Pang WY, Wang XL, Mok SK, Lai WP, Chow HK, Leung PC, Yao XS, Wong MS. 2010. Naringin improves bone properties in ovariectomized mice and exerts oestrogen-like activities in rat osteoblast-like (UMR-106) cells. Br J Pharmacol. 159(8):1693–1703.
   PubMed Web of Science ®Google Scholar
• Park SN, Lee HJ, Gu HA. 2014. Enhanced skin delivery and characterization of rutin-loaded ethosomes. Korean J Chem Eng. 31(3):485–489.
   Web of Science ®Google Scholar
• Patel GV, Patel VB, Pathak A, Rajput SJ. 2014. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation. Drug Dev Ind Pharm. 40(1):80–91.
   PubMed Web of Science ®Google Scholar
• Patil AG, Jobanputra AH. 2015. Rutin-chitosan nanoparticles: fabrication, characterization and application in dental disorders. Polym Plast Technol Eng. 54(2):202–208.
   Web of Science ®Google Scholar
• Patravale VB, Date AA, Kulkarni RM. 2004. Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol. 56(7):827–840.
   PubMed Web of Science ®Google Scholar
• Pietschmann P, Resch H, Krexner E, Woloszczuk W, Willvonseder R. 1991. Decreased serum osteocalcin levels in patients with postmenopausal osteoporosis. Acta Med Austriaca. 18(5):114–116.
   PubMedGoogle Scholar
• Potu BK, Rao MS, Nampurath GK, Chamallamudi MR, Prasad K, Nayak SR, Dharmavarapu PK, Kedage V, Bhat KM. 2009. Evidence-based assessment of antiosteoporotic activity of petroleum-ether extract of Cissus quadrangularis Linn. on ovariectomy-induced osteoporosis. Ups J Med Sci. 114(3):140–148.
   PubMed Web of Science ®Google Scholar
• Rabinow BE. 2004. Nanosuspensions in drug delivery. Nat Rev Drug Discov. 3(9):785–796.
   PubMed Web of Science ®Google Scholar
• Raisz LG. 2005. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest. 115(12):3318–3325.
   PubMed Web of Science ®Google Scholar
• Ramadan MF. 2012. Antioxidant characteristics of phenolipids (quercetin-enriched lecithin) in lipid matrices. Ind Crops Prod. 36(1):363–369.
   Web of Science ®Google Scholar
• Shariare MH, Altamimi MA, Marzan AL, Tabassum R, Jahan B, Reza HM, Rahman M, Ahsan G, Kazi M. 2019. In vitro dissolution and bioavailability study of furosemide nanosuspension prepared using design of experiment (DoE). Saudi Pharm J. 27(1):96–105.
   PubMed Web of Science ®Google Scholar
• Sharma S, Ali A, Ali J, Sahni JK, Baboota S. 2013. Rutin: therapeutic potential and recent advances in drug delivery. Expert Opin Investig Drugs. 22(8):1063–1079.
   PubMed Web of Science ®Google Scholar
• Srivastava S, Bankar R, Roy P. 2013. Assessment of the role of flavonoids for inducing osteoblast differentiation in isolated mouse bone marrow derived mesenchymal stem cells. Phytomedicine. 20(8-9):683–690.
   PubMed Web of Science ®Google Scholar
• Sun M, Gao Y, Pei Y, Guo C, Li H, Cao F, Yu A, Zhai G. 2010. Development of nanosuspension formulation for oral delivery of quercetin. J Biomed Nanotechnol. 6(4):325–332.
   PubMed Web of Science ®Google Scholar
• Tehrani AA, Omranpoor MM, Vatanara A, Seyedabadi M, Ramezani V. 2019. Formation of nanosuspensions in bottom-up approach: theories and optimization. DARU J Pharm Sci. 27(1):451–473.
   Web of Science ®Google Scholar
• Toth MJ, Poehlman ET, Matthews DE, Tchernof A, MacCoss MJ. 2001. Effects of estradiol and progesterone on body composition, protein synthesis, and lipoprotein lipase in rats. Am J Physiol Endocrinol Metab. 280(3):E496–E501.
   PubMed Web of Science ®Google Scholar
• Verma S, Gokhale R, Burgess DJ. 2009. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions. Int J Pharm. 380(1-2):216–222.
   PubMed Web of Science ®Google Scholar
• Verma S, Kumar S, Gokhale R, Burgess DJ. 2011. Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening. Int J Pharm. 406(1-2):145–152.
   PubMed Web of Science ®Google Scholar
• Wang Q, Huang J, Hu C, Xia N, Li T, Xia Q. 2017. Stabilization of a non-aqueous self-double-emulsifying delivery system of rutin by fat crystals and nonionic surfactants: preparation and bioavailability study. Food Funct. 8(7):2512–2522.
   PubMed Web of Science ®Google Scholar
• Wang T, Liu Q, Tjhioe W, Zhao J, Lu A, Zhang G, Xiang Tan R, Zhou M, Xu J, Tian Feng H. 2017. Therapeutic potential and outlook of alternative medicine for osteoporosis. Curr Drug Targets. 18(9):1051–1068.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li X, Wang L, Xu Y, Cheng X, Wei P. 2011. Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery. Int J Nanomedicine. 6:1497–1507.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang D, Liu Z, Liu G, Duan C, Jia L, Feng F, Zhang X, Shi Y, Zhang Q. 2010. In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery. Nanotechnology. 21(15):155104.
   PubMed Web of Science ®Google Scholar
• Wronski T, Cintron M, Dann L. 1988. Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Calcif Tissue Int. 43(3):179–183.
   PubMed Web of Science ®Google Scholar
• Xia D, Quan P, Piao H, Piao H, Sun S, Yin Y, Cui F. 2010. Preparation of stable nitrendipine nanosuspensions using the precipitation ultrasonication method for enhancement of dissolution and oral bioavailability. Eur J Pharm Sci. 40(4):325–334.
   PubMed Web of Science ®Google Scholar
• Yang J, Guo J, Yuan J. 2008. In vitro antioxidant properties of rutin. LWT – Food Science and Technology. 41(6):1060–1066.
   Web of Science ®Google Scholar
• Yu P, Lu S, Zhang S, Zhang W, Li Y, Liu J. 2017. Enhanced oral bioavailability and diminished food effect of lurasidone hydrochloride nanosuspensions prepared by facile nanoprecipitation based on dilution. Powder Technol. 312:11–20.
   Web of Science ®Google Scholar
• Zakeri-Milani P, Valizadeh H, Tajerzadeh H, Azarmi Y, Islambolchilar Z, Barzegar S, Barzegar-Jalali M. 2007. Predicting human intestinal permeability using single-pass intestinal perfusion in rat. J Pharm Pharm Sci. 10(3):368–379.
   PubMed Web of Science ®Google Scholar
• Zhang H-X, Wang J-X, Zhang Z-B, Le Y, Shen Z-G, Chen J-F. 2009. Micronization of atorvastatin calcium by antisolvent precipitation process. Int J Pharm. 374(1-2):106–113.
   PubMedGoogle Scholar